Low-dose endotoxin inhalation in healthy volunteers - a challenge model for early clinical drug development

BACKGROUND: Inhalation of endotoxin (LPS) induces a predominantly neutrophilic airway inflammation and has been used as model to test the anti-inflammatory activity of novel drugs. In the past, a dose exceeding 15–50 μg was generally needed to induce a sufficient inflammatory response. For human stu...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Janssen, Ole, Schaumann, Frank, Holz, Olaf, Lavae-Mokhtari, Bianca, Welker, Lutz, Winkler, Carla, Biller, Heike, Krug, Norbert, Hohlfeld, Jens M
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2013
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3635929/
https://ncbi.nlm.nih.gov/pubmed/23537365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2466-13-19
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak